Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.1 USD | -1.13% | -1.99% | -17.95% |
04-22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
03-28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.95% | 3.11B | |
+18.46% | 7.84B | |
+22.71% | 3.95B | |
-19.93% | 1.38B | |
-30.65% | 1.21B | |
+4.36% | 933M | |
-34.81% | 911M | |
-26.60% | 829M | |
-15.56% | 728M | |
-12.45% | 602M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 Revenue $248.4M, vs. Street Est of $236.5M